Hangzhou TianMuShan Pharmaceutical Enterprise Co. Ltd. provided earnings guidance for the year 2017. For the year, according to preliminary statistics of its financial department, the company predicts a year-on-year increase of between RMB 22,782,800 and RMB 28,782,800 in its net profit owned by shareholders of the company in 2017, a year-on-year increase between 1,872% and 2,364% (based on the disclosed statistics according to relevant regulations). The net loss belonging to shareholders of the company after excluding extraordinary profit and loss will be about between RMB 19.48 million and RMB 13.48 million.